Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer

Neoplasma

Volumn 53, Issue 3, 2006, Pages 242-246

  Mazurek, A ^a   Kuc, P ^a   Terlikowski, S ^a   Laudanski, T ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Angiogenesis; Endometrial cancer; Thymidine phosphorylase

Indexed keywords

EOSIN; HEMATOXYLIN; THYMIDINE PHOSPHORYLASE;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CANCER GRADING; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; POSTMENOPAUSE; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TUMOR DIFFERENTIATION;

EID: 33744899374     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. SUH D. Understanding angiogenesis and its clinical applications. Ann Clin Lab Sci 2000; 30(3): 235-245.
2. MAZUREK A, TELEGO M, PIERZYNSKI P, LAPUC G, NIKLINSKA W et al. Angiogenesis in endometrial cancer. Neoplasma 1998; 45(6): 360-364.
3. SALVESEN H, IVERSEN O, AKLSEN L. Independent prognostic importance of microvessel density in endometrial carcinoma. Br J Cancer 1998; 77(7): 1140-1144.
4. TSUKAGOSHI S, SAGA Y, SUZUKI N, FUJIOKA A, NAKAGAWA F et al. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Int J Oncol 2003; 22: 961-967.
5. NIKLINSKA W, BURZYKOWSKI T, CHYCZEWSKI L, NIKLINSKI J. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis. J Lung Cancer 2001; 34(2): 59-64.
6. GIATROMANOLAKI A, SIVRIDIS E, KOUKOURAKIS M, GEORGOULIAS V, GATTER K et al. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? Oncol Res 1999; 11: 205-212.
7. HATA K, KAMIKAWA T, ARAO S, TASHIRO H, KATABUCHI H et al. Expression of thymidine phosphorylase gene in epithelial ovarian cancer. Br J Cancer 1999; 79: 1848-1854.
8. FUJIWAKI R, IIDA K, KANASAKI H, OZAKI T, HATA K et al. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Human Pathol 2002; 33(2): 213-219.
9. FUJIWAKI R, HATA K, IIDA K, KOIKE M, MIYAZAKI K. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol 1998; 68: 247-252.
10. KAUKAURAKIS MI, GIETROMANOLAKI A, O'BYRNE K, COMLEY M, WHITEHOUSE R et al. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 1997; 75: 477-481.
11. MAEDA K, CHUNG Y, OGAWA S, TAKATSUKA S, KANG S et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73: 884-888.
12. TAKEBAYASHI Y, MIYADARA K, AKIYAMA S, HOKITA S, YAMADAK et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996; 87: 288-295.
13. HAN JY, HONG EK, LEE SY, YOON SM, LEE DH et al. Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer. J Clin Pathol 2005; 58(6): 650-654.
14. YAMASHITA J, OGAWA M, ABE M, NISHIDA M. Platelet-derived endothelial growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer. Chest 1999; 116(1): 206-211.
15. FUJIWAKI R, HATA K, NAKAYAMA K, FUKUMOTO M, MIYAZAKI K. Thymidylate synthase expression in epithelial ovarian cancer: relationship with thymidine phosphorylase expression and prognosis. Oncology 2000; 59(2): 152-157.
16. HATA K, FUJIWAKI R, MAEDE Y, NAKAYAMA K, FUKUMOTO M et al. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity. Gynecol Oncol 2000; 77(1): 26-34.
17. HATA K, FUJIWAKI R, NAKAYAMA K, MAEDE Y, FUKUMOTO M et al. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor. Anticancer Res 2000; 20: 3941-3949.
18. WOJCIK-KROWIRANDA K, MIOSZCZAK-ZABORSKA E, GOTTWALD L, BIENKIEWICZ A. Thymidine phosphorylase activity and neo-angiogenesis in ovarian cancer. Ginekol Pol 2003; 74(9): 911-917.
19. KATAOKA A, YUASA T, KAGEYAMA S, IWAKI H, HIGUCHI K et al. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer. Oncol Rep 2005; 13(4): 597-600.
20. KIKUNO N, YOSHINO T, URAKAMI S, SHIGENO K, KISHI H et al. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer. Anticancer Res 2003; 23: 1305-1312.
21. MAZUREK A, PIERZYNSKI P, KUC P, KOPINSKI P, TERLIKOWSKI S et al. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer. Neoplasma 2004; 51(3): 193-197.
22. MAZUREK A, PIERZYNSKI P, NIKLINSKA W, CHYCZEWSKI L, LAUDANSKI T. Angiogenesis and Bcl-2 protein expression in patients with endometrial cancer. Neoplasma 2002; 49(3): 149-154.
23. BREMER G, TIEBOSCH A, VAN DER PUTTEN H, SCHOUTEN H, DE HAAN J et al. Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol 1996; 174: 126-131.
24. WIGGINS D, GRANAI C, STEINHOFF M, CALABRESI P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995; 56: 353-356.
25. GUIDI A, ABU J, BERSE B, JACKMAN R, TOGNAZZI K et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995; 87: 1237-1245.
26. ABULAFIA O, TRIEST W, SHERER D, HANSEN C, GHEZZI F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol 1995; 86(4): 479-485.
27. TANAKA Y, KOBAYASHI H, SUZUKI M, KANAYAMA N, SUZUKI M et al. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Human Pathology 2002; 11: 1105-1113.
28. FOX SK, WESTWOOD M, MAGHADDAM A, COMLEY M, TURLEY H et al. The antigenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996; 73: 275-280.